Washington committee hears competing views on bill to distribute state stockpile of abortion medication Lawmakers heard testimony for and against SSB 5917, which would clarify how the state can donate or sell previously purchased mifepristone and misoprostol and authorize the Department of Corrections to coordinate distribution to health providers and tribal organizations.

Emotional testimonies flooded the Washington House as lawmakers debated a pivotal bill to streamline the distribution of essential abortion medications, igniting fierce support and opposition.

Read the full story

#WA #CivicAccountability #CitizenPortal #PublicHealth #AccessToMedicine

Texas Board of Pharmacy adopts stricter sterile‑compounding standards after debate over batch size, testing and costs The Texas State Board of Pharmacy adopted amendments to sterile compounding rules that change batch‑size limits, testing and beyond‑use‑date (BUD) provisions. The board accepted targeted edits after extensive public comment from compounding pharmacies raising cost and access concerns.

The Texas State Board of Pharmacy has just adopted new sterile compounding rules that could drastically impact patient access and operational costs for local pharmacies.

Read the full story

#TX #PharmacyRegulations #PublicHealth #CitizenPortal #AccessToMedicine #TexasPharmacy

Nurses, students and health advocates back bill to allow stock albuterol in schools Committee staff and witnesses described SB 59‑51, which would authorize schools to maintain a stock supply of albuterol accessed under a uniform OSPI/DOH procedure; nurses supported the bill but DOH requested an amendment to use its public process rather than a direct statutory standing order.

A new bill could revolutionize student safety in Washington by allowing schools to stock albuterol, ensuring that no child has to miss class due to asthma emergencies.

Click to read more!

#WA #PublicHealth #StudentSafety #AccessToMedicine #CitizenPortal

Massachusetts legislators propose bill to ensure minors' access to epinephrine Legislators introduce bill guaranteeing access to epinephrine for minors in Massachusetts.

Massachusetts legislators are taking a bold step to ensure that minors have guaranteed access to life-saving epinephrine.

Learn more here

#MA #CitizenPortal #AccessToMedicine #YouthSafety #PublicHealth

Massachusetts House committee recommends passage of drug discount program discrimination bill House Bill 4490 seeks to prohibit discrimination against participants in the 340B program

Massachusetts is taking a bold step to protect the 340B program participants from discrimination—will this change the landscape of healthcare in the state?

Click to read more!

#MA #CitizenPortal #AccessToMedicine #CivicAccountability #HealthEquity

📥 You can read the full report here: buff.ly/hf2vUSe

#HealthEquity #GlobalHealth #TheMaxFoundation #CancerCare #AccessToMedicine

Vaccination Rewards ensures people can access the medical services they trust—early, fairly, and with dignity. vaccinationrewards.org
#TrustedCare #AccessToMedicine

Our CEO, @jayiyer.bsky.social, is in Barcelona this week to speak at Reuters Pharma 2025 #REPharma. She’ll be moderating a keynote panel on how the #pharma industry can advance equitable #AccesstoMedicine through innovation, sustainable models & collaboration. Learn more➡️ bit.ly/3Ec4II3

Senate passes bill ensuring equal pay for referees in high school sports The committee approved a bill mandating equal pay for all sports referees in high schools.

Maryland is taking bold steps to ensure equal pay for sports referees and improve healthcare access for diabetes patients—two bills that could transform lives and promote fairness in our communities.

Learn more here

#MD #MarylandSports #CitizenPortal #AccessToMedicine #HealthEquity

As governments prepare for the 4th High-level Meeting on #NCDs, they must push the #pharma industry for concrete commitments to address access gaps in #LMICs. Our latest briefing outlines the key priorities for this engagement. Read it here➡️ bit.ly/3DXQZo5 #UNGA #AccesstoMedicine #GlobalHealth

USAID funding cuts jeopardise breakthrough drugs and research | Access to Medicine

In her latest article for @devex.com, @cathedavison.bsky.social spoke with our Director of Research, Claudia Martínez, about the far-reaching impact of #USAID funding cuts on #GlobalHealth research. Read more➡️ bit.ly/41SJkPQ #AccesstoMedicine #AccesstoHealthcare #HealthEquity

In an op-ed for @devex.com, our CEO, @jayiyer.bsky.social, highlights how recent US aid cuts & rising #healthcare nationalism are forcing Africa to rethink its reliance on external support, underscoring the urgent need for more made-in-Africa medicine. Read more➡️ bit.ly/3XsKRe0 #AccesstoMedicine

The Access to Medicine Foundation joins the World EPA Congress 2025 | Access to Medicine

Our team is at #EPAConf in Amsterdam today, engaging with key stakeholders on #healthcare access & #pharma accountability. Our CEO, @jayiyer.bsky.social, will deliver a keynote speech sharing insights on global #HealthEquity from the 2024 #AccesstoMedicine Index #ATMI24. Learn more➡️ bit.ly/4isqENQ

Virginia General Assembly passes bill enhancing medical cannabis labeling and delivery New bill improves cannabis product labeling and delivery options for patient access in Virginia.

Virginia just took a major step to enhance patient safety and access to medical cannabis with new labeling and delivery regulations!

Click to read more!

#VA #PatientSafety #HealthCareReform #VirginiaMedicalCannabis #AccessToMedicine #CitizenPortal

In an op-ed for @weforum.org, the Foundation's CEO, @jayiyer.bsky.social, argues that equitable #AccesstoMedicine isn't just a moral imperative but a strategic opportunity for sustainable returns & discusses the key insights from #ATMI24. Read the op-ed➡️ bit.ly/40WPLlC #HealthEquity #ESG

#NCDs are the number one cause of death & disability worldwide. The 2024 #AccesstoMedicine Index #ATMI24 finds that voluntary licensing continues to be a severely underutilised mechanism in NCDs, with 26/27 licences analysed covering communicable diseases. Learn more➡ bit.ly/3NUREIk

#ATMI24 spotlights eight Best Practices that exemplify how #pharma companies are driving progress toward equitable #AccesstoMedicine, each highlighting proven actions that not only address current challenges but also elevate industry standards. Learn more➡ bit.ly/4goFOCf #HealthEquity #GlobalHealth

Has the #pharma industry advanced in achieving global #HealthEquity? The 2024 #AccesstoMedicine Index #ATMI24 finds that while some modest progress has been made, the potential for improving access is still far from realised. Read the key findings➡ bit.ly/3ra4URP
#GlobalHealth #EquitableAccess

Out of 66 R&D projects for HIV and TB, only 11 focus on children -just 17%. That’s not enough.

If we don’t speak up and act - we are complicit in leaving them behind. The solutions exist. Now we need the commitment to deliver.

#GlobalHealth #AccessToMedicine #PaediatricHealth #HIV #TB

ESG Investor's Emmy Hawker spoke with the Foundation’s CEO, @jayiyer.bsky.social, about the financial & social risks of the US President’s decision to limit access to affordable, life-saving medicines & #healthcare. Read more➡️ bit.ly/3Q1cmr7 #AccesstoMedicine #HealthEquity #ESG #investing